Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

G.S.P. Solution

Other

Phase 1/2 Most advanced trial (none active)
1 Registered trials

What is G.S.P. Solution?

G.S.P. Solution is an investigational drug studied in Galactose Single Point (GSP), Residual Liver Function.

At a glance

Drug type
Other
Therapy area
Endocrine
In trials of
CAH
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04546022 Phase 1/2 Galactose Single Point (GSP), Residual Liver Function Completed CAH

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Galactose Single Point (GSP), Residual Liver Function

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.